EP3110454
METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION
:
EP einkaleyfi: Þýðing ekki lögð inn:
24.2.2015:
18.11.2020:
15752803.5
:
23.2.2035
:
METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION
24.2.2015
18.11.2020
:
Sangamo Therapeutics, Inc.:
501 Canal Blvd. Suite A100, Richmond, CA 94804, US
:
HOLMES, Michael C.:
Richmond, California 94804, US
:
WECHSLER, Thomas:
Richmond, California 94804, US
:
201461943865 P:
24.2.2014:
US
:
US2015017302:
24.2.2015
:
A61K 48/00, C12N 15/64, C12N 5/10